Usal - MediNews
2.8K views | +0 today
Follow
 
Scooped by Usalbiomedica
onto Usal - MediNews
Scoop.it!

Charrosfera: la tecnología y la innovación "se mueven" en Salamanca

Charrosfera: la tecnología y la innovación "se mueven" en Salamanca | Usal - MediNews | Scoop.it
Charrosfera: la tecnología y la innovación "se mueven" en Salamanca. Una treintena de profesionales salmantinos crean una asociación para impulsar proyectos basados en nuevas tecnologías .
more...
No comment yet.
Usal - MediNews
Noticias médico-sanitarias en la red
Curated by Usalbiomedica
Your new post is loading...
Your new post is loading...
Scooped by Usalbiomedica
Scoop.it!

Libro Blanco de la Nutrición en España

Libro Blanco de la Nutrición en España | Usal - MediNews | Scoop.it

 

 "El Libro Blanco es fruto de un convenio específico firmado entre la Agencia Española de Seguridad Alimentaria y Nutrición (AESAN) y la propia Fundación Española de la Nutrición (FEN), supone una "hoja de ruta" de la nutrición en sus numerosas facetas, todas de gran actualidad..."

Usalbiomedica's insight:

Libro Blanco de la Nutrición en España. Fundación Española de la Nutrición: Madrid: FEN. 2013

more...
Scooped by Usalbiomedica
Scoop.it!

Patient Specific Implants: Medgadget Hangout with CEO of Episurf (Fri, 1pm EST) |

Patient Specific Implants: Medgadget Hangout with CEO of Episurf (Fri, 1pm EST) | | Usal - MediNews | Scoop.it

"Episurf Medical is a Swedish company that produces patient-specific orthopedic implants rosemary-cunningham-thomasdesigned to match the unique anatomy of every surgical case. The company just partnered with Touch Surgery, a firm that’s building surgical virtual reality applications, to create a simulation of how to use its Episealer line of personalized knee resurfacing implants. 


Tomorrow (Friday Oct 28) at 1pm EST we’ll be speaking with Rosemary Cunningham Thomas, the CEO of Episurf about her company’s technology and what the future holds for this rapidly evolving field. 


 Please join us by coming back to this very page, at which time there will be a Google Hangout window here through which you’ll be able to join the discussion.


 Link: Episurf Medica (http://episurf.com/)

more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

LEO Pharma lance le concours #épidermeimaginaire

LEO Pharma lance le concours #épidermeimaginaire | Usal - MediNews | Scoop.it
Le laboratoire LEO Pharma lance un concours photo en ligne pour soutenir les patients atteints de Psoriasis. Présentation.
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

New research examines use of nanotechnology to improve delivery of drugs to HIV patients

New research examines use of nanotechnology to improve delivery of drugs to HIV patients | Usal - MediNews | Scoop.it
 SOURCE October 21, 2016 New research led by the University of Liverpool aims to improve the administration and availability of drug therapies to HIV patients through the use of nanotechnology. The research, conducted by the collaborative nanomedicine research programme led by Pharmacologist Professor Andrew Owen and Materials Chemist Professor Steve Rannard, examined the use of nanotechnology to improve the delivery of drugs to HIV patients. Nanotechnology is the manipulation of matter on an atomic, molecular, and supramolecular scale. Nanomedicine is the application of nanotechnology to the prevention and treatment of disease in the human body. This evolving discipline has the potential to dramatically change medical science and is already having an impact in a number of clinically used therapies and diagnostics worldwide. Leading research Currently, the treatment of HIV requires daily oral dosing of HIV drugs, and chronic oral dosing has significant complications that arise from
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

New Stroke Technology: Stent and Pressure Activated Nanoparticles to Bust Clots

New Stroke Technology: Stent and Pressure Activated Nanoparticles to Bust Clots | Usal - MediNews | Scoop.it
Some ischemic strokes are now successfully treated using intravascular clot retrieval devices, but in many instances this option is not advised. Moreover,
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Early cancer diagnosis variation 'unacceptable'

Early cancer diagnosis variation 'unacceptable' | Usal - MediNews | Scoop.it
Vital opportunities to diagnose cancer patients in England earlier and increase their survival chances are being missed, experts are warning.
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Cuatro de cada 10 españoles mayores de 35 años presentan hipertensión arterial

Cuatro de cada 10 españoles mayores de 35 años presentan hipertensión arterial | Usal - MediNews | Scoop.it

"La Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) informa, con motivo del Día Nacional de la Hipertensión que se celebrará este sábado, de que en España más de un 40% de la población entre 35 y 64 años presenta hipertensión arterial y de que ese porcentaje supera el 65% entre los mayores de 65 años.

De hecho, la hipertensión arterial ocupa el primer puesto en la lista de problemas de salud en las consultas en Atención Primaria y es el primer factor de riesgo para el desarrollo de enfermedades cardiovasculares..."

more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Childhood MMR vaccination rates fall - BBC News

Childhood MMR vaccination rates fall - BBC News | Usal - MediNews | Scoop.it
The proportion of two-year-old children having the MMR vaccine has fallen, according to NHS statistics.
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

High Quality 3D Printed Model Hearts Printed Within Hours of MRI Scans

High Quality 3D Printed Model Hearts Printed Within Hours of MRI Scans | Usal - MediNews | Scoop.it

"At MIT and Boston Children's Hospital, researchers worked out a system allowing clinicians to take an MRI scan of patients' hearts and create 3D printed models of the organs within hour".

more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Autistic and non-autistic brain differences isolated for first time

Autistic and non-autistic brain differences isolated for first time | Usal - MediNews | Scoop.it
The functional differences between autistic and non-autistic brains have been isolated for the first time, following the development of a new methodology for analysing…
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

La secuenciación masiva revela al fin a la mayoría de hipoacusias hereditarias.DMedicina.com

La secuenciación masiva revela al fin a la mayoría de hipoacusias hereditarias.DMedicina.com | Usal - MediNews | Scoop.it
Paneles de diagnóstico genéticos desvelan un 60 por ciento de las sorderas poslocutivas. La investigación en terapia con células madre busca corregir las neuropatías auditivas.
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Activating genes on demand

Activating genes on demand | Usal - MediNews | Scoop.it

"When it comes to gene expression – the process by which our DNA provides the recipe used to direct the synthesis of proteins and other molecules that we need for development and survival – scientists have so far studied one single gene at a time. A new approach developed by Harvard geneticist George Church, Ph.D., can help uncover how tandem gene circuits dictate life processes, such as the healthy development of tissue or the triggering of a particular disease, and can also be used for directing precision stem cell differentiation for regenerative medicine and growing organ transplants".

more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

New Molecule Binds to Cancer's DNA, Prevents Replication

New Molecule Binds to Cancer's DNA, Prevents Replication | Usal - MediNews | Scoop.it
Researches at Bielefeld University in Germany have come upon a new method of disrupting the spread of cancer using molecules that bind to DNA. The team dev
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Recupera tu ritmo

Recupera tu ritmo | Usal - MediNews | Scoop.it

 Campaña de la Fundación AstraZeneca para pacientes con EPOC.


"Ayudarte a recuperar tu ritmo y mejorar tu calidad de vida es el objetivo de esta campaña, puesta en marcha por la Fundación AstraZeneca, en la que te enseñamos a manejar la enfermedad y superar los obstáculos que te impiden disfrutar más de tu familia y alcanzar tus metas. La EPOC es una enfermedad crónica que causa dificultad para respirar, pero su diagnóstico no implica necesariamente tener que renunciar a vivir tu vida. Mantenerte activo, entrenar tu capacidad pulmonar y seguir las recomendaciones de tu médico pueden incidir, positivamente, en tu calidad de vida y en la mejora progresiva de tu respiración pulmonar. ¡No dejes que la EPOC te frene! Aquí encontrarás unos sencillos consejos y ejercicios que te ayudarán, poco a poco, a recuperar y mantener tu ritmo".

more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Gold Nanoparticles Fight Off Pancreatic Tumor Growth |

Gold Nanoparticles Fight Off Pancreatic Tumor Growth | | Usal - MediNews | Scoop.it
A research team from University of Oklahoma, Mayo Clinic, Mount Sinai, and University of Missouri have shown that gold nanoparticles can help stop the grow
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Did You Have A Genetic Test? Analyze Your Raw Data At Home! - The Medical Futurist

Did You Have A Genetic Test? Analyze Your Raw Data At Home! - The Medical Futurist | Usal - MediNews | Scoop.it
Personalized medicine allows you not only to take genetic tests at home, but also to analyse your DNA in your living room. Let me show you how.
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

New Cancer Cure uses Nanotechnology: AND cost could be cheap thanks to breakthrough with Algae

New Cancer Cure uses Nanotechnology: AND cost could be cheap thanks to breakthrough with  Algae | Usal - MediNews | Scoop.it
SOURCE November 10, 2015 Nanotechnology has long been considered among the best hopes for a cancer cure, but now perhaps the greatest hurdle to using nanotechnology — the science of creating microscopic machines the size of a single cell, molecule or even atom — to combat the feared and deadly disease may have been overcome. That obstacle, of course, is simply the cost of manufacturing the nanotechnology needed to infiltrate the human body to seek out and destroy individual cancer cells while leaving heathy cells and tissue unharmed. Not only would a cancer cure using artificially created nanoparticles cost so much that the medicine would likely be unavailable for widespread use, the process itself is also dangerous and environmentally destructive, requiring the use of deadly, industrial chemicals. The chemicals not only create toxic waste that can damage the environment, but can render the nanoparticles — that is, the microscopic machines — themselves toxic to humans. But a team led
more...
No comment yet.
Rescooped by Usalbiomedica from Cancer Immunotherapy Review
Scoop.it!

Oncolytic Maraba Virus Vaccine Technology | Turnstone Biologics

Oncolytic Maraba Virus Vaccine Technology | Turnstone Biologics | Usal - MediNews | Scoop.it

The Foundation – Maraba: The ideal oncolytic virus

The Maraba platform represents Turnstone’s lead oncolytic immunotherapy agent.  Maraba was bioselected from rhabdovirus isolates from around the world as the most potent tumour lytic strain. The final product was developed through iterative genetic engineering of Maraba to maximize its inherent safety and potency profile.  

Oncolytic Maraba Highlights:

Extremely potent at killing almost all types of human tumour cells testedHighly attenuated in normal healthy human cellsHumans have no pre-existing immune responses to impede its systemic deliveryCan be engineered to carry multi-transgene payloadsEasy to manufacture as a GMP biologic product

 

The Direct Cancer-Killing Properties of Turnstone’s Oncolytic Viral Immunotherapy Platform


Via Krishan Maggon
more...
Krishan Maggon 's curator insight, October 28, 2015 5:52 PM

FDA approval of Amgen oncolytic virus immunotherapy has put the  spotlight on another oncolytic immunotherapy start up,

 

Canadian TurnStone Biologics

 

Its lead product is in Phase I trials and the company plans to combine it with a checkpoint inhibitor (PD1/2 inhibitor)

Scooped by Usalbiomedica
Scoop.it!

Un paso adelante para obtener células madre de sangre en laboratorio

Un paso adelante para obtener células madre de sangre en laboratorio | Usal - MediNews | Scoop.it

"Un equipo del Instituto Hospital del Mar de Investigaciones Médicas de Barcelona ha descubierto la forma de activar la proteína Notch para producir células madre hematopoyéticas en laboratorio. Según los autores, el hallazgo es importante en medicina regenerativa ya que permitirá en el futuro producir células aptas para trasplantes hematológicos a aquellos enfermos que no tengan donantes compatibles".

Usalbiomedica's insight:

Referencia bibliográfica:

Leonor Gama-Norton, Eva Ferrando, Cristina Ruiz-Herguido, Zenhy Liu, Jordi Guiu, Abul B.M.M.K. Islam, Sung-Uk Lee, Minhong Yan, Cynthia J. Guidos, Nuria López-Bigas, Takahiro Maeda, Lluis Espinosa, Raphael Kopan & Anna Bigas“Notch signal strength controls cell fate in the haemogenic endothelium”. Nature Communications. DOI: 10.1038/ncomms9510.

more...
No comment yet.
Rescooped by Usalbiomedica from Buzz e-sante
Scoop.it!

Soutien gorge connecté pour le dépistage cancer du sein iTBra de la société Cyrcadia health

Soutien gorge connecté pour le dépistage cancer du sein iTBra de la société Cyrcadia health | Usal - MediNews | Scoop.it
Pour dépister les cancers du sein, la société Cyrcadia Health a développé un patch connecté, capable de déceler la présence d’une cellule cancéreuse.

Via Festival Communication Santé, Rémy TESTON
more...
Bge Innovation's curator insight, September 27, 2015 4:32 PM

iTBra : système de détection thermique pour le dépistage du cancer du sein

Scooped by Usalbiomedica
Scoop.it!

El antidepresivo Paxil no es seguro para los adolescentes, según un análisis reciente: MedlinePlus en español

El antidepresivo Paxil no es seguro para los adolescentes, según un análisis reciente: MedlinePlus en español | Usal - MediNews | Scoop.it
El antidepresivo Paxil no es seguro para los adolescentes, según un análisis reciente
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

9 Ways Technology Helps Manage Alzheimer’s and Parkinson’s Disease

9 Ways Technology Helps Manage Alzheimer’s and Parkinson’s Disease | Usal - MediNews | Scoop.it
With all these technological advances, improvements and new devices coming to the market, we could significantly improve the lives of Parkinson’s and Alzheimer’s disease patients. They could change...
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Five research papers that revolutionised health

Five research papers that revolutionised health | Usal - MediNews | Scoop.it
Five pieces of scientific research that changed the face of medicine.
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Ayudas Fundación BBVA a Equipos de Investigación Científica (Convocatoria 2015)

Ayudas Fundación BBVA a Equipos de Investigación Científica (Convocatoria 2015) | Usal - MediNews | Scoop.it

"Las ayudas a proyectos de investigación objeto de esta convocatoria responden al compromiso de la Fundación BBVA con el impulso de la investigación científica y la creación cultural, y su proyección a la sociedad, como forma de ampliar las oportunidades individuales y colectivas".

more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Multitasking hunger neurons also control compulsive behaviors

Multitasking hunger neurons also control compulsive behaviors | Usal - MediNews | Scoop.it
In the absence of food, neurons that normally control appetite initiate complex, repetitive behaviors seen in obsessive-compulsive disorder (OCD), and anorexia nervosa, according to…
more...
No comment yet.
Scooped by Usalbiomedica
Scoop.it!

Identifican alteraciones en el sistema de recompensa cerebral de las personas con obesidad

Identifican alteraciones en el sistema de recompensa cerebral de las personas con obesidad | Usal - MediNews | Scoop.it

"Expertos españoles han descrito diferencias anatómicas en las estructuras cerebrales implicadas en el refuerzo de la conducta en un grupo de personas con obesidad. Este hallazgo puede servir para avanzar en la prevención y en la aplicación de tratamientos más individualizados o por subgrupos de pacientes".

Usalbiomedica's insight:

Referencia del artículo:

Marqués-Iturria, I.; Scholtens, L.H.; Garolera, M.; Pueyo, R.; García-García, I.; González-Tartiere, P.; Segura, B.; Junqué, C.; Sender-Palacios. M.J.; Vernet-Vernet, M.; Sánchez-Garre, C.; De Reus, M.A.; Jurado, M.A.; Van den Heuvel, M.P. «Affected connectivity organization of the reward system structure in obesity».Neuroimage, 111, 2015, p. 100-106. DOI: 10.1016/j.neuroimage.2015.02.012

more...
No comment yet.